Fajardo, Kyzine .
HRN: 21-48-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/28/2022
07/04/2022
IVTT
530mg
Q8
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes